{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:03:04Z","timestamp":1773338584477,"version":"3.50.1"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2020,5,13]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Lymphatic filariasis (LF) is a parasitic disease that has been targeted for\nelimination through the Mass Drug Administration (MDA.) Although the MDA started in the Ankobra\ncommunity in Ghana in 2000, LF prevalence as reported in 2014 was relatively high\n(4.5%). Non-compliance to the MDA has been associated with the persistent LF prevalence in endemic\nregions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study determined the factors associated with the non-compliance to the MDA\namong patients living in the Ankobra community, Ghana.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A cross-sectional study using a one-stage cluster sampling method was used to collect\ndata between June and July, 2017 in Ankobra. Questionnaires were used to collect data from\nhealth workers, the MDA drug distributors and study participants in Ankobra. Data analysis was\nperformed using STATA 14. Logistic regression was used to measure the degree of association\nbetween the dependent (non-compliance) and independent variables. Non-compliance rate was defined\nas the percentage of individuals who self-reported that they did not actually swallow the\ndrugs provided during the MDA.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The MDA coverage and non-compliance rates were 73.5% (147\/200) and 33.33%\n(49\/147) respectively. The main reason for non-compliance was fear of drug adverse events\n(75.51%, 37\/49). Thought of \u201cnot being susceptible to LF\u201d was significantly associated with the\nnon-compliance (aOR= 2.83, [CI= 1.15, 6.98]).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Health education about the susceptibility of residents getting LF disease in endemic\ncommunity must be intensified to improve compliance to MDA medication ingestion and thus\nmeet the Global Elimination of Lymphatic Filariasis by 2020.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526519666190206210808","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T07:53:55Z","timestamp":1549526035000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana"],"prefix":"10.2174","volume":"20","author":[{"given":"Ilo","family":"Dicko","sequence":"first","affiliation":[{"name":"International Center for Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaya Ibrahim","family":"Coulibaly","sequence":"additional","affiliation":[{"name":"International Center for Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modibo","family":"Sangar\u00e9","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry of Bamako, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bismark","family":"Sarfo","sequence":"additional","affiliation":[{"name":"School of Public Health (SPH), University of Ghana, Legon, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscillia Awo","family":"Nortey","sequence":"additional","affiliation":[{"name":"School of Public Health (SPH), University of Ghana, Legon, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2016","unstructured":"Global programme to eliminate lymphatic filariasis: progress report. Weekly epidemiological reports (Vol 38) Available from:[Accessed November 15, 2016];2016","journal-title":"Weekly epidemiological reports (Vol 38)"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000317","volume":"2","author":"Ottesen E.A.","year":"2008","unstructured":"Ottesen E.A.; Hooper P.J.; Bradley M.; Biswas G.; The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008,2(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003319","volume":"8","author":"Ramaiah K.D.","year":"2014","unstructured":"Ramaiah K.D.; Ottesen E.A.; Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis 2014,8(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020336","volume":"2","author":"Molyneux D.H.","year":"2005","unstructured":"Molyneux D.H.; Hotez P.J.; Fenwick A.; \u201cRapid-impact interventions\u201d: how a policy of integrated control for Africa\u2019s neglected tropical diseases could benefit the poor. PLoS Med 2005,2(11)","journal-title":"PLoS Med"},{"key":"ref=5","year":"2016","unstructured":"Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis [Accessed Decmber 12, 2016];2016","journal-title":"Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","volume":"79","author":"Kyelem D.","year":"2008","unstructured":"Kyelem D.; Biswas G.; Bockarie M.J.; Bradley M.H.; El-Setouhy M.; Fischer P.U.; Henderson R.H.; Kazura J.W.; Lammie P.J.; Njenga S.M.; Ottesen E.A.; Ramaiah K.D.; Richards F.O.; Weil G.J.; Williams S.A.; Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg 2008,79(4),480-484","journal-title":"Am J Trop Med Hyg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1756-3305-5-259","volume":"5","author":"de Souza D.K.","year":"2012","unstructured":"de Souza D.K.; Koudou B.; Kelly-Hope L.A.; Wilson M.D.; Bockarie M.J.; Boakye D.A.; Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis. Parasit Vectors 2012,5,259","journal-title":"Parasit Vectors"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1179\/000349802125001735","volume":"96","author":"Gyapong J.O.","year":"2002","unstructured":"Gyapong J.O.; Kyelem D.; Kleinschmidt I.; Agbo K.; Ahouandogbo F.; Gaba J.; Owusu-Banahene G.; Sanou S.; Sodahlon Y.K.; Biswas G.; Kale O.O.; Molyneux D.H.; Roungou J.B.; Thomson M.C.; Remme J.; The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 2002,96(7),695-705","journal-title":"Ann Trop Med Parasitol"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005280","volume":"11","author":"Biritwum N.K.","year":"2017","unstructured":"Biritwum N.K.; de Souza D.K.; Marfo B.; Odoom S.; Alomatu B.; Asiedu O.; Yeboah A.; Hervie T.E.; Mensah E.O.; Yikpotey P.; Koroma J.B.; Molyneux D.; Bockarie M.J.; Gyapong J.O.; Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators. PLoS Negl Trop Dis 2017,11(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"Krentel A.","year":"2013","unstructured":"Krentel A.; Fischer P.U.; Weil G.J.; A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis 2013,7(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/her\/cyt042","volume":"28","author":"Nandha B.","year":"2013","unstructured":"Nandha B.; Krishnamoorthy K.; Jambulingam P.; Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India. Health Educ Res 2013,28(4),591-598","journal-title":"Health Educ Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2049-9957-3-31","volume":"3","author":"Hussain M.A.","year":"2014","unstructured":"Hussain M.A.; Sitha A.K.; Swain S.; Kadam S.; Pati S.; Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty 2014,3,31","journal-title":"Infect Dis Poverty"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3329\/jhpn.v31i2.16380","volume":"31","author":"Roy R.N.","year":"2013","unstructured":"Roy R.N.; Sarkar A.P.; Misra R.; Chakroborty A.; Mondal T.K.; Bag K.; Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India. J Health Popul Nutr 2013,31(2),171-177","journal-title":"J Health Popul Nutr"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004905","volume":"10","author":"Senyonjo L.","year":"2016","unstructured":"Senyonjo L.; Oye J.; Bakajika D.; Biholong B.; Tekle A.; Boakye D.; Schmidt E.; Elhassan E.; Factors associated with ivermectin non-compliance and its potential role in sustaining onchocerca volvulus transmission in the west region of Cameroon. PLoS Negl Trop Dis 2016,10(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048395","volume":"7","author":"Njomo D.W.","year":"2012","unstructured":"Njomo D.W.; Amuyunzu-Nyamongo M.; Magambo J.K.; Njenga S.M.; The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya. PLoS One 2012,7(11)","journal-title":"PLoS One"},{"key":"ref=16","first-page":"180","volume":"5","author":"Offei M.","year":"2014","unstructured":"Offei M.; Anto F.; Bacteriology","journal-title":"J Bacteriol Parasitol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2883-6-11","volume":"6","author":"Weerasooriya M.V.","year":"2007","unstructured":"Weerasooriya M.V.; Yahathugoda C.T.; Wickramasinghe D.; Gunawardena K.N.; Dharmadasa R.A.; Vidanapathirana K.K.; Weerasekara S.H.; Samarawickrema W.A.; Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria J 2007,6,11","journal-title":"Filaria J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-016-1311-1","volume":"9","author":"Shuford K.V.","year":"2016","unstructured":"Shuford K.V.; Turner H.C.; Anderson R.M.; Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors 2016,9,29","journal-title":"Parasit Vectors"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4066\/AMJ.2010.479","volume":"3","author":"Pattanshetty S.","year":"2010","unstructured":"Pattanshetty S.; Kumar A.; Kumar R.; Rao C.R.; Badiger S.; Rashmi R.; College K.M.; Mass drug administration to eliminate lymphatic filariasis in Southern India. Australas Med J 2010,3(13),847-850","journal-title":"Australas Med J"},{"key":"ref=20","first-page":"237","volume":"46","author":"Kumar A.","year":"2009","unstructured":"Kumar A.; Kumar P.; Nagaraj K.; Nayak D.; Ashok L.; Ashok K.; A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. J Vector Borne Dis 2009,46(3),237-240","journal-title":"J Vector Borne Dis"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946201759023","volume":"59","author":"Cabral S.","year":"2017","unstructured":"Cabral S.; Bonfim C.; Oliveira R.; Oliveira P.; Guimar\u00e3es T.; Brand\u00e3o E.; Aguiar-Santos A.M.; Medeiros Z.; Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration. Rev Inst Med Trop S\u00e3o Paulo 2017,59","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","volume":"9","author":"Babu B.V.","year":"2004","unstructured":"Babu B.V.; Kar S.K.; Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 2004,9(6),702-709","journal-title":"Trop Med Int Health"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4269\/ajtmh.12-0491","volume":"89","author":"Abd Elaziz K.M.","year":"2013","unstructured":"Abd Elaziz K.M.; El-Setouhy M.; Bradley M.H.; Ramzy R.M.R.; Weil G.J.; Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program. Am J Trop Med Hyg 2013,89(2),260-264","journal-title":"Am J Trop Med Hyg"},{"key":"ref=24","first-page":"101","volume":"48","author":"Karmakar P.R.","year":"2011","unstructured":"Karmakar P.R.; Mitra K.; Chatterjee A.; Jana P.K.; Bhattacharya S.; Lahiri S.K.; A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India. J Vector Borne Dis 2011,48(2),101-104","journal-title":"J Vector Borne Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.actatropica.2010.08.021","volume":"120","author":"King J.D.","year":"2011","unstructured":"King J.D.; Zielinski-Gutierrez E.; Pa\u2019au M.; Lammie P.; Improving community participation to eliminate lymphatic filariasis in American Samoa. Acta Trop 2011,120(Suppl. 1),S48-S54","journal-title":"Acta Trop"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/169714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T07:11:33Z","timestamp":1594969893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/169714\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526519666190206210808","relation":{},"ISSN":["1871-5265"],"issn-type":[{"value":"1871-5265","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}